WallStreetZenWallStreetZen

NASDAQ: VTRS
Viatris Inc Stock Ownership - Who owns Viatris?

Insider buying vs selling

Have Viatris Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Rajiv MalikDirector2024-09-12139,681$11.66
$1.63MSell
Rajiv MalikDirector2024-09-1260,319$11.71
$706.58kSell
Rajiv MalikDirector2024-08-3050,000$12.00
$600.00kSell
Rajiv MalikDirector2024-08-2850,000$11.90
$595.10kSell
Rajiv MalikDirector2024-08-23100,000$11.75
$1.18MSell
Rajiv MalikDirector2024-08-22100,000$11.73
$1.17MSell
Rajiv MalikDirector2024-08-21100,000$11.75
$1.18MSell
Rajiv MalikDirector2024-06-14264,300$10.18
$2.69MSell
Rajiv MalikDirector2024-06-1385,660$10.52
$900.71kSell
Brian RomanChief Legal Officer2024-05-2889,419$10.38
$928.44kSell

1 of 6

VTRS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VTRS insiders and whales buy or sell their stock.

VTRS Shareholders

What type of owners hold Viatris Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc11.76%140,323,062$1.63BInstitution
Laboratories Abbott11.37%135,750,000$1.58BInsider
Blackrock Inc7.76%92,667,874$1.08BInstitution
Products Abbott5.26%62,782,018$729.53MInsider
State Street Corp5.20%62,110,442$721.72MInstitution
Davis Selected Advisers4.82%57,535,953$668.57MInstitution
Price T Rowe Associates Inc4.76%56,823,030$660.28MInstitution
Pacer Advisors Inc3.21%38,311,514$445.18MInstitution
Invesco Ltd2.57%30,713,547$356.89MInstitution
Geode Capital Management LLC2.43%28,996,949$336.94MInstitution

1 of 3

VTRS vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VTRS81.83%17.73%Net SellingNet Selling
RDY14.44%0.00%
NBIX70.07%29.93%Net SellingNet Selling
CTLT76.55%23.45%Net SellingNet Selling
ITCI79.69%20.31%Net SellingNet Buying

Viatris Stock Ownership FAQ

Who owns Viatris?

Viatris (NASDAQ: VTRS) is owned by 81.83% institutional shareholders, 17.73% Viatris insiders, and 0.44% retail investors. Laboratories Abbott is the largest individual Viatris shareholder, owning 135.75M shares representing 11.37% of the company. Laboratories Abbott's Viatris shares are currently valued at $1.55B.

If you're new to stock investing, here's how to buy Viatris stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.